Related references
Note: Only part of the references are listed.Real-time PCR-based method for the rapid detection of extended RAS mutations using bridged nucleic acids in colorectal cancer
Takao Iida et al.
CLINICA CHIMICA ACTA (2019)
Relationship between formalin reagent and success rate of targeted sequencing analysis using formalin fixed paraffin embedded tissues
Kenji Amemiya et al.
CLINICA CHIMICA ACTA (2019)
Molecular subtype switching in early-stage gastric cancers with multiple occurrences
Shinya Takaoka et al.
JOURNAL OF GASTROENTEROLOGY (2019)
Influence of NUDT15 variants on hematological pictures of patients with inflammatory bowel disease treated with thiopurines
Yuichiro Kojima et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2018)
New therapeutic targets for pulmonary sarcomatoid carcinomas based on their genomic and phylogenetic profiles
Takahiro Nakagomi et al.
Oncotarget (2018)
Simple and Rapid Method to Obtain High-quality Tumor DNA from Clinical-pathological Specimens Using Touch Imprint Cytology
Kenji Amemiya et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2018)
Clinical Validation of Newly Developed Multiplex Kit Using Luminex xMAP Technology for Detecting Simultaneous RAS and BRAF Mutations in Colorectal Cancer: Results of the RASKET-B Study
Hiroya Taniguchi et al.
NEOPLASIA (2018)
Intrinsic HER2 V777L mutation mediates resistance to trastuzumab in a breast cancer patient
Yosuke Hirotsu et al.
MEDICAL ONCOLOGY (2017)
Very early response of circulating tumour-derived DNA in plasma predicts efficacy of nivolumab treatment in patients with non-small cell lung cancer
Yuki Iijima et al.
EUROPEAN JOURNAL OF CANCER (2017)
Genetic basis of a common tumor origin in the development of pancreatic mixed acinar-neuroendocrine-ductal carcinoma: A case report
Atsushi Takano et al.
ONCOLOGY LETTERS (2017)
Distribution of circulating tumor DNA in lung cancer: analysis of the primary lung and bone marrow along with the pulmonary venous and peripheral blood
Taichiro Goto et al.
ONCOTARGET (2017)
Detection of tumor-derived DNA dispersed in the airway improves the diagnostic accuracy of bronchoscopy for lung cancer
Taichiro Goto et al.
ONCOTARGET (2017)
Simultaneous detection of genetic and copy number alterations in BRCA1/2 genes
Yosuke Hirotsu et al.
ONCOTARGET (2017)
Stepwise addition of genetic changes correlated with histological change from well-differentiated to sarcomatoid phenotypes: a case report
Taichiro Goto et al.
BMC CANCER (2017)
BRCA1 and BRCA2 mutations in Japanese patients with ovarian, fallopian tube, and primary peritoneal cancer
Ikuko Sakamoto et al.
CANCER (2016)
Comparison between two amplicon-based sequencing panels of different scales in the detection of somatic mutations associated with gastric cancer
Yosuke Hirotsu et al.
BMC GENOMICS (2016)
Targeted and exome sequencing identified somatic mutations in hepatocellular carcinoma
Yosuke Hirotsu et al.
HEPATOLOGY RESEARCH (2016)
Touch imprint cytology with massively parallel sequencing (TIC-seq): a simple and rapid method to snapshot genetic alterations in tumors
Kenji Amemiya et al.
CANCER MEDICINE (2016)
Clinical Validation of a Multiplex Kit for RAS Mutations in Colorectal Cancer: Results of the RASKET (RAS KEy Testing) Prospective, Multicenter Study
Takayuki Yoshino et al.
EBIOMEDICINE (2015)
Multigene panel analysis identified germline mutations of DNA repair genes in breast and ovarian cancer
Yosuke Hirotsu et al.
MOLECULAR GENETICS & GENOMIC MEDICINE (2015)
Extended RAS mutations and anti-EGFR monoclonal antibody survival benefit in metastatic colorectal cancer: a meta-analysis of randomized, controlled trials
M. J. Sorich et al.
ANNALS OF ONCOLOGY (2015)
Melting Curve Analysis after T Allele Enrichment (MelcaTle) as a Highly Sensitive and Reliable Method for Detecting the JAK2V617F Mutation
Soji Morishita et al.
PLOS ONE (2015)
Detection of BRCA1 and BRCA2 germline mutations in Japanese population using next-generation sequencing
Yosuke Hirotsu et al.
MOLECULAR GENETICS & GENOMIC MEDICINE (2015)
Rapid Detection of DNMT3A R882 Mutations in Hematologic Malignancies Using a Novel Bead-Based Suspension Assay with BNA(NC) Probes
Velizar Shivarov et al.
PLOS ONE (2014)
Comprehensive molecular characterization of human colon and rectal cancer
Donna M. Muzny et al.
NATURE (2012)
Frequency of KRAS, BRAF, and NRAS Mutations in Colorectal Cancer
Cecily P. Vaughn et al.
GENES CHROMOSOMES & CANCER (2011)
Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis
Wendy De Roock et al.
LANCET ONCOLOGY (2010)
Wild-Type BRAF Is Required for Response to Panitumumab or Cetuximab in Metastatic Colorectal Cancer
Federica Di Nicolantonio et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer
Rafael G. Amado et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Design, synthesis, and properties of 2′,4′-BNANC:: A bridged nucleic acid analogue
S. M. Abdur Rahman et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2008)
K-ras mutations and benefit from cetuximab in advanced colorectal cancer
Christos S. Karapetis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Open-label phase III trial of panitumumab plus best supportive care compared with best supportive care alone in patients with chemotherapy-refractory metastatic colorectal cancer
Eric Van Cutsem et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Phase II trial of cetuximab in patients with refractory colorectal cancer that expresses the epidermal growth factor receptor
LB Saltz et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer
D Cunningham et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
2′-O,4′-C-methylene bridged nucleic acid modification promotes pyrimidine motif tripler DNA formation at physiological pH -: Thermodynamic and kinetic studies
H Torigoe et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Share Paper
